ConductScience.org, home

Paper32037523

Phosphoglycerate dehydrogenase promotes proliferation and bortezomib resistance through increasing reduced glutathione synthesis in multiple myeloma.

Wu X and 16 others. Br J Haematol, 2020. Cited by 60 papers, by iCite.

Cite this record

ConductScience Library. Phosphoglycerate dehydrogenase promotes proliferation and bortezomib resistance through increasing reduced glutathione synthesis in multiple myeloma. Papers, record 32037523. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32037523

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Phosphoglycerate dehydrogenase promotes proliferation and bortezomib resistance through increasing reduced glutathione synthesis in multiple myeloma.
PubMed
Journal
Br J Haematol
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
60
iCite
Relative citation ratio, by iCite
2.54
iCite
Revised in PubMed
2021-03-02
PubMed

Authors17

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wu XXuan
2Xia JJiliang
3Zhang JJingyu
4Zhu YYinghong
5Wu YYangbowen
6Guo JJiaojiao
7Chen SShilian
8Lei QQian
9Meng BBin
10Kuang CChunmei
11Feng XXiangling
12He YYanjuan
13Shen YYi
14Li XXin
15Qiu LLugui
16Li GGuancheng
17Zhou WWenhttps://orcid.org/0000-0003-4085-7714

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
BortezomibMajor topic
GlutathioneMajor topic
Multiple MyelomaMajor topic
Phosphoglycerate DehydrogenaseMajor topic
Animals
Cell Line, Tumor
Cell Proliferation
Humans
Mice

Source PubMed

Download CSV of topics

Grants17

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
198465Postdoctoral Science Foundation of Central South UniversityInternationalPubMedPubMed
ZLXD2017004Strategic Priority Research Program of Central South UniversityInternationalPubMedPubMed
2018M640762China Postdoctoral Science FoundationInternationalPubMedPubMed
2018YFA0107800Ministry of Science and Technology of ChinaInternationalPubMedPubMed
81570205National Natural Science Foundation of ChinaInternationalPubMedPubMed
81630007National Natural Science Foundation of ChinaInternationalPubMedPubMed
81800209National Natural Science Foundation of ChinaInternationalPubMedPubMed
81974010National Natural Science Foundation of ChinaInternationalPubMedPubMed
2019JJ50838Hunan Province Natural Science Foundation of ChinaInternationalPubMedPubMed
2018zzts079Fundamental Research Funds for the Central Universities of Central South UniversityInternationalPubMedPubMed
2019zzts1010Fundamental Research Funds for the Central Universities of Central South UniversityInternationalPubMedPubMed
2019zzts177Fundamental Research Funds for the Central Universities of Central South UniversityInternationalPubMedPubMed
2019zzts716Fundamental Research Funds for the Central Universities of Central South UniversityInternationalPubMedPubMed
2019zzts717Fundamental Research Funds for the Central Universities of Central South UniversityInternationalPubMedPubMed
CX20190233Hunan Provincial Innovation Foundation for PostgraduatesInternationalPubMedPubMed
CSUZC201948Open Sharing Fund for the Large-scale Instruments And Equipments of Central South UniversityInternationalCSUZC201948PubMedNIH RePORTER
CSUZC201949Open Sharing Fund for the Large-scale Instruments And Equipments of Central South UniversityInternationalCSUZC201949PubMedNIH RePORTER

Download CSV of grants

Cited by45

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.

PMIDTitleJournalYearIn PapersSource
42724467PHGDH in cancer: a narrative review of its functions beyond serine metabolism.Transl Cancer Res2026https://conductscience.org/library/papers/42724467PubMed
41725790The role of antioxidants in multiple myeloma: diagnostic, prognostic, and therapeutic applications: a narrative review.Ther Adv Hematol2026https://conductscience.org/library/papers/41725790PubMed
41674932PHGDH knockdown activates autophagic flux to suppress migration and invasion of gastric cancer cells.Transl Cancer Res2026https://conductscience.org/library/papers/41674932PubMed
41486146PHGDH at the crossroads: metabolic plasticity, metastatic paradoxes, and therapeutic reconnaissance in cancer.J Biomed Sci2026https://conductscience.org/library/papers/41486146PubMed
41398969Nutritional approaches in combating therapeutic resistance and enhancing treatment efficacy in cancer: the impact of ketogenic diets.Nutr Metab (Lond)2025https://conductscience.org/library/papers/41398969PubMed
40919131Metabolic Reprogramming: A Crucial Contributor to Anticancer Drug Resistance.MedComm (2020)2025https://conductscience.org/library/papers/40919131PubMed
40616775Clioquinol as a new therapy in epilepsy: From preclinical evidence to a proof-of-concept clinical study.Epilepsia2025https://conductscience.org/library/papers/40616775PubMed
40200920The oligosaccharyltransferase complex is an essential component of multiple myeloma plasma cells.Mol Ther Oncol2025https://conductscience.org/library/papers/40200920PubMed
39962071MAPK13 phosphorylates PHGDH and promotes its degradation via chaperone-mediated autophagy during liver injury.Cell Discov2025https://conductscience.org/library/papers/39962071PubMed
39595653Supplementation of Oocytes by Microinjection with Extra Copies of mtDNA Alters Metabolite Profiles and Interactions with Expressed Genes in a Tissue-Specific Manner.Biomolecules2024https://conductscience.org/library/papers/39595653PubMed
39201634Different Strategies to Overcome Resistance to Proteasome Inhibitors-A Summary 20 Years after Their Introduction.Int J Mol Sci2024https://conductscience.org/library/papers/39201634PubMed
38791048Cellular Responses Induced by NCT-503 Treatment on Triple-Negative Breast Cancer Cell Lines: A Proteomics Approach.Biomedicines2024https://conductscience.org/library/papers/38791048PubMed
38615172Mechanisms of the role of proto-oncogene activation in promoting malignant transformation of mature B cells.Zhong Nan Da Xue Xue Bao Yi Xue Ban2024https://conductscience.org/library/papers/38615172PubMed
38577610PHGDH is Key to a Prognostic Multigene Signature and a Potential Therapeutic Target in Acute Myeloid Leukemia.J Cancer2024https://conductscience.org/library/papers/38577610PubMed
38500772Factors determining the sensitivity to proteasome inhibitors of multiple myeloma cells.Front Pharmacol2024https://conductscience.org/library/papers/38500772PubMed
37587064High expression of VARS promotes the growth of multiple myeloma cells by causing imbalance in valine metabolism.Zhong Nan Da Xue Xue Bao Yi Xue Ban2023https://conductscience.org/library/papers/37587064PubMed
37248571[Latest Findings on the Mechanism of the Interaction Between Multiple Myeloma Cells and Bone Marrow Microenvironment].Sichuan Da Xue Xue Bao Yi Xue Ban2023https://conductscience.org/library/papers/37248571PubMed
37190313The Ubiquitin-Proteasome System in Tumor Metabolism.Cancers (Basel)2023https://conductscience.org/library/papers/37190313PubMed
37190210Intestinal Microbes and Hematological Malignancies.Cancers (Basel)2023https://conductscience.org/library/papers/37190210PubMed
37187454Serine Metabolic Reprogramming in Tumorigenesis, Tumor Immunity, and Clinical Treatment.Adv Nutr2023https://conductscience.org/library/papers/37187454PubMed

See all 45 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
PHGDH26227PubTator's text mininghttps://conductscience.org/library/genes/26227NCBI Gene
SDC16382PubTator's text mininghttps://conductscience.org/library/genes/6382NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32037523

GET https://conductscience.org/api/papers/v1/32037523/cited_by?page=2